Abstract
Treatment for gender dysphoria and the desire to live in the opposite gender requires hormonal, anatomic, and psychosocial changes. Concurrent with increased acceptance of fertility preservation is an increase in the acceptance and encouragement of transgender individuals. Undergoing gender affirming treatment no longer means the loss of reproductive potential. The medical community has a responsibility to meet the reproductive needs of transgender patients through education, empowerment, and advocacy. Whether transitioning from male to female, female to male, presenting individually or as a couple with a cis- or transgender partner, there are options available. Advancements in technologies including sperm banking, oocyte retrieval, cryopreservation, and in vitro fertilization techniques have expanded the options for transgender individuals. In addition, third-party reproduction allows for family building options and plays a role in the management and counseling of transgender patients. Working closely with a reproductive specialist maximizes fertility preservation and reproductive options.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Gooren LJ, Giltary EJ, Bunck MC. Long-term treatment of transsexuals with cross sex hormones: extensive personal experience. J Clin Endocrinol Metab. 2008;93:19–25.
Dhejne C, Lichtenstein P, Boman M, Johansson AL, Langstrom N, Landem M. Long-term follow-up of transsexual persons undergoing sex reassignment surgery: cohort study in Sweden. PLoS ONE. 2011;6:e16885.
Judge C, O’Donovan C, Callaghan G, Gaoatswe G, O’Shea D. Gender dysphoria - prevalence and co-morbidities in an Irish adult population. Front Endocrinol. 2014;5:87.
Byne W, Bradley SJ, Coleman E, Eyler AE, Green R, Menvielle EJ, Meyer-Bahlburg HF, Pleak RR, Tompkins DA. American psychiatric task force on treatment of gender identity disorder. Report of the American psychiatric association task force on treatment of gender identity disorder. Arch Sex Behav. 2012;41:759–96.
Anger JT, Gilbert BR, Goldstein M. Cryopreservation of sperm: indications, methods and results. J Urol. 2002;170:1079–84.
Tanagho EA. Anatomy of the genitourinary tract. In: Smith’s general urology, 17th ed. McGraw Hill Lange; 2008. p. 1–16.
Turek P. Male infertility. In: Smith’s general urology, 17th ed. McGraw Hill Lange; 2008. p. 684–715.
Schneider F, Kliesch S, Schlatt S, Neuhaus N. Andrology of male-to-female transsexuals: influence of cross-sex hormone therapy on testicular function. Andrology. 2017;5:873–80.
Moore E, Wisniewski A, Dobs A. Endocrine treatment of transsexual people: a review of treatment regimens, outcomes, and adverse effects. J Clin Endocrinol Metab. 2003;88:3467–73.
Murray KS, James A, McGeady JB, et al. The effect of the new 2010 World Health Organization criteria for semen analyses on male infertility. Fertil Steril. 2012;98(6):1428–31.
Cooper TG, Noonan E, von Eckardstein S, Auger J, Baker HW, Behre HM, et al. World Health Organization reference values for human semen characteristics. Hum Reprod Update. 2010;16:231–45.
Polland A, Berookhim BM. Fertility concerns in men with genitourinary malignancies: treatment dilemmas, fertility options, and medicolegal considerations. Urol Oncol Semin Orig Invest. 2016;34:399–406.
van Casteren N, van Santbrink EJ, van Inzen W, Romijn JC, Dohle GR. Use rate and assisted reproduction technologies outcome of cryopreserved semen from 629 cancer patients. Fertil Steril. 2008;90:245–50.
Kuczynski W, Dhont M, Grygoruk C, Grochowski D, Wolczynski S, Szamatowicz M. The outcome of intracytoplasmic injection of fresh and cryopreserved ejaculated spermatozoa—a prospective randomized study. Hum Reprod. 2001;16:2109.
Clarke GN, de Liu Y, Baker HW. Recovery of human sperm motility and ability to interact with the human zona pellucida after more than 28 years of storage in liquid nitrogen. Fertil Steril. 2006;86:721–2.
Horne G, Atkinson AD, Pease EH, Logue JP, Brison DR, Lieberman BA. Live birth with sperm cryopreserved for 21 years prior to cancer treatment: case report. Hum Reprod. 2004;19:1448–9.
Hovay Y, Dan-Goor M, Yaffe H, Almagor M. Electroejaculation before chemotherapy in adolescents and young men with cancer. Fertil Steril. 2001;75:811–3.
Goldstein M. Surgical management of male infertility. In: Cambell-Walsh urology, 11th ed. Elsevier; 2015. p. 580–611.
Schlegel PN, Palermo GD, Alikani M, et al. Micropuncture retrieval of epididymal sperm with in vitro fertilization: importance of in vitro micro-manipulation techniques. Urology. 1995;46:238–41.
Vernaeve V, Verheyen G, Goosens A, Van Steirteghem A, Devroey P, Tournaye H. How successful is repeat testicular sperm extraction in patients with azoospermia? Hum Reprod. 2006;21:1551–4.
Berookhim BM, Schlegel PN. Azoospermia due to spermatogenic failure. Urol Clin North Am. 2014;41:97–113.
Honaramooz A, Behboodi E, Megee SO, et al. Fertility and germline transmission of donor haplotype following germ cell transplantation in immunocompetent goats. Biol Reprod. 2003;69:1260.
Hermann BP, Sukhwani M, Winkler F, et al. Spermatogonial stem cell transplantation into rhesus testes regenerates spermatogenesis producing functional sperm. Cell Stem Cell. 2012;11:715.
Parrington J, Coward K, Gadea J. Sperm and testis mediated DNA transfer as a means of gene therapy. Syst Biol Reprod Med. 2011;57:35.
Light AD, Obedin-Maliver J, Sevelius JM, Kerns JL. Transgender men who experienced pregnancy after female-to-male gender transitioning. Obstet Gynecol. 2014;124(6):1120–7.
Hembree WC, Cohen-Kettenis P, Delemarre-van de Waal HA, et al. Endocrine treatment of transsexual persons: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2009;94:3132–54.
Jadoul P, Guilmain A, Squifflet J, Luyckx M, Votino R, Wyns C, Dolmans MM. Efficacy of ovarian tissue cryopreservation for fertility preservation: lessons learned from 545 cases. Hum Reprod. 2017;32(5):1046–54.
Donnez J, Silber S, Andersen CY, Demeestere I, Piver P, Meirow D, et al. Children born after autotransplantation of cryopreserved ovarian tissue. A review of 13 live births. Ann Med. 2011;43(6):437–50.
Dittrich R, Hackl J, Lotz L, Hoffmann I, Beckmann MW. Pregnancies and live births after 20 transplantations of cryopreserved ovarian tissue in a single center. Fertil Steril. 2015;103(2):462–8.
Corkum KS, Laronda MM, Rowell EE. A review of reported surgical techniques in fertility preservation for prepubertal and adolescent females facing a fertility threatening diagnosis or treatment. Am J Surg. 2017;21(4):695–700.
Fasano G, Dechene J, Antonacci R, Biramane J, Vannin AS, Van Langedonckt A, Devreker F, Demeestere I. Outcomes of immature oocytes collected from ovarian tissue for cryopreservation in adult and prepubertal patients. Reprod Biomed Online. 2017;34(6):575–82.
Duncan FE. Egg quality during the pubertal transition-is youth all it’s cracked up to be? Front Endocrinol (Lausanne). 2017;4(8):226.
Tamar R, Zil G. Case report: induced lactation in a transgender woman. Transgender Health. 2018;3(1).
Wein AJ, Kavoussi LR, Partin AW, Peters CA, editors. Campbell-Walsh urology, 11th ed. Philadelphia: Elsevier; 2016.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Telis, L., Baum, S., Singer, T., Berookhim, B.M. (2019). Fertility Issues in Transgender Care. In: Poretsky, L., Hembree, W. (eds) Transgender Medicine. Contemporary Endocrinology. Humana Press, Cham. https://doi.org/10.1007/978-3-030-05683-4_11
Download citation
DOI: https://doi.org/10.1007/978-3-030-05683-4_11
Published:
Publisher Name: Humana Press, Cham
Print ISBN: 978-3-030-05682-7
Online ISBN: 978-3-030-05683-4
eBook Packages: MedicineMedicine (R0)